Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.17 – $0.94
35% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Revenue | $0 | $11.5K | $3.8K |
| Cost of revenue | $0 | $9.7K | $7.3K |
| Gross profit | $0 | $1.8K | −$3.5K |
| Gross margin | — | 15.9% | -93.4% |
| R&D | $0 | $0 | $0 |
| Operating income | −$56.4K | −$26.2K | −$31.9K |
| EBITDA | −$41.7K | −$11.5K | $55.2K |
| Net income | −$56.4K | −$25.8K | $51.4K |
| Net margin | — | -224.4% | 1370.5% |
| EPS (diluted) | -0.01 | -0.00 | 0.01 |
Annual figures · source: Financial Modeling Prep
L A M Y
No one on the platform currently holds LMMY.
No tracked institution reports a position in LMMY as of their last filing.
No one on the platform has traded LMMY yet.
| $99617 |
| — |
| MGNCMag Magna Corp. | $0.75 | +0.00% | $5M | — |
| RPDLRapid-Line Inc. | $0.30 | +0.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$MAJI $LMMY https://moneychannelnyc.vids.io/videos/109adbb01a19e5c49a/roth-capital-conference-2026-michael-sheikh-ceo-nextel-medical 🚀📊💰
View on StockTwits ↗@griffinrc23 Is there a website for $LMMY that can provide details about the new biotech pipeline ?
View on StockTwits ↗$LMMY Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to combat cancer and other serious diseases. For the full interview, please visit: https://lnkd.in/eYYsbmhc
View on StockTwits ↗$MAJI $LMMY Great interview and DD info... lots of hints of big catalysts coming 👇👇👇👇👇 https://x.com/MicroCapTweets/status/1996386349889536191?t=L_mZ9I1DRVdx4qQJltZKJw&s=19
View on StockTwits ↗$LMMY LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. https://finance.yahoo.com/news/lamy-completes-strategic-acquisition-cancer-152800337.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.